-

U.S. Physicians Still Willing to Participate in Healthcare Market Research During Coronavirus Pandemic

New Research Brief from Trinity Life Sciences and Toluna Now Available

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences solutions, and Toluna, a leading consumer intelligence platform that delivers insights on demand, announced today the availability of a new brief regarding the impact of COVID-19 on healthcare market research.

The co-sponsored brief, based on a survey of approximately 560 healthcare providers in the U.S., finds that physicians in private practices or community settings have an increased availability to participate in research. This increase in availability appears to be driven partially by a decrease in on-site patient volume.

In fact, 49% of HCPs surveyed indicate an increased availability to participate in research studies, while 35% indicate their availability was the same as before COVID-19.

“Response rates among healthcare professionals have remained steady during the COVID-19 global crisis. We are continuously aware and respectful of those on the front lines. However, overall, we have found physicians and other healthcare professionals are ready and willing to participate in market research,” said Steve Orlick, Senior Vice President and Team Lead for Healthcare for Toluna. “We have observed an uptick in several specialties as treatment patterns for seeing patients and patient volume have shifted temporarily.”

“It is not surprising that physicians in hospitals that are treating COVID-19 patients have lower availability for market research at this time,” said Clive Mendonca, PhD, Director, Trinity. “However, as more patients push their regularly scheduled appointments or elective procedures, we do see that doctors in private practices and community offices have high availability and willingness to participate in research studies now as their time permits.”

For access to the brief, please visit COVID-19 Briefing Series: Impact of COVID-19 on Healthcare Market Research.

About Toluna
Toluna is a technology company connecting brands with consumers for digital qualitative and quantitative research. We deliver insights on demand through a full spectrum of end-to-end solutions that map customer journeys, develop new products and much more. Toluna is powered by an innovative platform, best-in-class methodologies and a community panel that is 30+ million members strong. An ITWP company, we employ 1,400 people in 24 offices across six continents. Please visit us at tolunacorporate.com.

About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Beth Kichener
Toluna
203-247-9290
beth.kitchener@toluna.com

Trinity Life Sciences


Release Versions

Contacts

Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Beth Kichener
Toluna
203-247-9290
beth.kitchener@toluna.com

More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom